One of the most common questions founders ask after understanding what clinical validation is: How much evidence do I actually need?
The answer is a category, not a number. Where your product sits determines what evidence is expected of it by regulators, investors, clinical partners, and the users trusting it with their health.
Here is how to figure out where yours sits.
The distinction that changes everything
Before the category breakdown, one principle that applies across all of them:
There is a meaningful difference between describing what your product does and claiming what it achieves.
“Track your symptoms over time” is a description. “Identify patterns that may indicate endometriosis” is a claim. Both might appear in the same product, but they do not carry the same evidence burden.
Every product makes some claims, even implicitly. The question is whether your evidence supports the specific claims you are making. Get clear on that distinction before anything else.
Educational content products
Examples: menstrual health apps, reproductive anatomy resources, condition awareness tools
These products share health information. They teach. They do not tell a specific user what is happening in their body or what they should do about it.
Evidence expectations are relatively low in regulatory terms. What is non-negotiable is clinical accuracy. Your content should be reviewed by qualified clinicians, grounded in current evidence, and clearly framed as educational rather than diagnostic.
Common mistake: assuming a lower regulatory bar means no clinical input is needed. Inaccurate health content causes harm regardless of regulatory classification, and in women’s health, where misinformation is already widespread, it damages trust faster than almost anything else.
Symptom trackers
Examples: period trackers, pain logging tools, mood and energy journals
These products help users observe and record their experience. The critical question is what they do with that data.
A tracker that helps a user log symptoms and share them with a doctor sits in a very different regulatory category from one that interprets those symptoms or generates a prediction. The first is a documentation tool. The second is making a clinical claim.
Evidence expectations scale directly with interpretation. Pure tracking carries a lower bar, but the moment your product adds a layer of meaning to what it collects, like a pattern, a risk score, or a recommendation, your evidence requirements might change.
Common mistake: adding AI-generated insight to a tracker without recognizing that this fundamentally changes your regulatory and evidence position.
Wellness apps
Examples: stress management tools, sleep support, nutrition guidance
Wellness products sit in an interesting middle ground. They are not making clinical claims, but they are touching things that matter clinically.
The regulatory bar is generally lower than for medical devices, but the evidence expectations from investors, clinical partners, and increasingly sophisticated users are rising. Claiming your app “regulates hormones” or “corrects cortisol imbalance” without evidence for those claims is the kind of thing that would not pass without scrutiny.
Common mistake: using clinical language without clinical evidence. Words like “treats,” “corrects,” “heals,” or “regulates” are claims. They require evidence, regardless of your regulatory classification.
Clinical decision-support tools and diagnostic products
Examples: tools that help clinicians make decisions, products that identify or predict a condition
This is where the evidence bar rises significantly and where many founders most seriously underestimate the work involved.
If your product influences a clinical decision, i.e., if a clinician or patient acts differently because of what your tool tells them, you are in regulated territory in most jurisdictions. Clinical validation here is not optional. It is the cost of entry.
The evidence required includes analytical validation (does your tool measure what it claims to measure), clinical validation (does that measurement translate meaningfully to the outcome you are targeting), and in most cases a formal regulatory submission.
Common mistake: building the product first and planning validation later. In this category, validation must be part of the product design from the beginning. Retrofitting it is significantly more expensive and frequently insufficient.
How your evidence bar shifts as your product evolves
Your product will not stay in one category indefinitely. Features get added and claims expand. An educational app adds a symptom tracker. A tracker adds predictive insights. Each evolution carries evidence implications that need to be anticipated, not discovered after the fact.
Build the habit of asking at every product milestone: Have my claims changed? If the answer is yes, your evidence strategy needs to catch up.
Now that you know what your product needs. Part 3 is about how to build it.
Better Woman Health is published weekly.
Subscribe at betterwomanhealth.com to get it directly in your inbox.
Clinical Credibility Toolkit
The Clinical Credibility Toolkit is a free resource designed for FemTech founders building digital tools for women’s health.
It includes the Clinical Credibility Scorecard, a 28-question assessment that helps you identify gaps in your clinical foundation, evidence strategy, safety architecture, and investor readiness, and the Red Flag Detection Checklist, a 25-question assessment that tells you whether your symptom-tracking app can actually detect and act on medical red flags, not just log them.
If you are preparing to pitch, pursuing healthcare partnerships, or simply want to know where your product stands clinically, start here.
Access the toolkit → app.ayomide.me
Thanks for reading. See you soon!
Dr. Ayomide O.
Clinical Strategy & African Market Advisory
Find me on LinkedIn or Book a 1:1 Call
